Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Todd Pope received 2.2 MILLION in compensation last year and just gave himself a whopping 21% pay increase. Now he’s diluting 15 MILLION shares.
All for a RASD that is 10 years old, outdated, & without one single commercial sale.
Wake up!
Surgical data has been recorded on ALF since 2010 and it all bad.
Charts? Why? This company has a 10 year old robot that has never produced a profit. Intuitive Surgical has retired a complete robotic system that’s less than 1/2 of that time.
Yet Pope wants you to think it has a “place” in the surgical arena. Shameful
Not as good? Would you want a family member to undergo surgery with a device that’s “not as good”, would you expect a surgeon to use a product that is “not as good” as existing technology being utilized worldwide?
BTW, IM going to Demo Alf tomorrow. The reps already hate me after my questions to “no 4th arm” they just say.... Another assistant can retract. LMFAO!
These guys hate me. Worse yet.... docs doing demos say it’s crap. LOL
Ok. I’m at SAGES. The activity around Alf Is comical. Two surgeons from back east demoed this junk and said “ it’s just a space between us and our patients” no advantage with it.
And there ya have it. Two docs, one Davinci and another Laparoscopic surgeon that were completely unimpressed.
Yep. I nailed it.
Look at the “Haptics” ignore the non articulating instruments. LOL.
This guy has obviously NEVER placed a foot inside the OR, but hey , whatever makes you feel better.
“Sidebar: Btw, while the doubters/shorts would have us believed that the Senhance is bulky with huge footprint that took up space in the operation room; however, after watching the video above, I realized Senhance might be specifically designed this way so that it provided space for the supporting staffs to surround the patient as in a normal operation. The heavy base for each surgical arm provided stability and the “long” arms allowed the bases to be “out-of-the-way” so that supporting staffs can surround the patient with ease. It also creates space for the hybrid surgery mentioned above.”
This guy knows nothing of surgical technique, asepsis, OR workflow, etc.
Like I said, whatever makes you feel better.
Counter traction is not a “Theory”, it’s basic dissection technique. Pope relies on uneducated investors not understanding the basics.
Snippets? Nope. That’s all based on 18 years of surgical experience.
Every surgery requires something called “Exposure” and this is not debatable. If a surgeon or assistant cannot see the surgical field they simply can not perform a surgical procedure, it is a simple fact of dissection.
So how does a surgical team obtain exposure of target anatomy?
Through a process called “dissection” that requires hands, fingers and instruments. Four hands (and sometimes 5) are utilized to “expose” and operate on the anatomical structure that need to be excised (look it up). Laparoscopic procedure does not allow for easy retraction that is realized during open procedures. So mechanical (RASD) retraction is necessitated with a robotic 4th arm.
Prior to Laparoscopic surgery, surgeons could utilize open surgical techniques for retraction with either a Bookwalter, Thompson or Balfour. These instruments can not be used with Laparoscopic procedures.
Too bad for ALF.
ALF was CE marked in Europe in 2013 and they allowed 4 arms to necessitate counter traction. The rooms were HUGE and they were utilized for CLINICAL trials. They were also NOT PRACTICAL.
The FDA knew this and so did Pope. Pope went with it anyways and (as per his statements) was (working) with the FDA to obtain “Approval”. Well, Pope got approval on his newly named “Alf” only after he either removed the 4th arm or the FDA flat out rejected it. I suspect the latter as Pope stated, “In order to expedite FDA approval” on a Conference call LOL.
Bottom line... Pope wanted ALF Alf Approval no matter what. He doesn’t care about investors, he doesn’t care about product and he CERTAINLY DOES NOT CARE ABOUT PATIENTS.
He cares about lining his pockets no matter what.
Buyer Beware.
People that think a 4 arm (Still non viable) platform wasn’t submitted need to look no further than Europe and the CR mark that cleared 4 arms for SOFAR back in 2013 and where 4 arms are being used.
Anyone thinking Pope only submitted a 3 arm platform knows ABSOLUTELY NOTHING as to how surgery works (and Pope relies on that).
For the last time.... You can not operate without counter traction and without a 4th arm ALF can’t do it.
You just named everything that they did with Spider as well. Like spider, ALF will be on the shelf, collecting dust.
3 Arms was NOT what Pope wanted and anyone claiming they only submitted 3 arms has 100% Zero knowledge of how surgery works. You MUST have counter traction and 3 arms does not allow it. Sofar got away with it in Europe where 4 arms are used (explain that one Mr. Pumper). The FDA either told Pope in advance 4 arms would not get approved or they axed it after submission. Either way, they AXED the 4th arm.
SUPPORT? The “Bears” LOL.
Transenterix has never reported a profit in their existence. Charts mean nothing here.
Transenterix has never produced a single device that has lasted in the OR.
Until a profit is realized, charts mean NOTHING.
Transenterix, under Todd Pope, will NEVER make a dime. Pope is a salesman with no education in healthcare or engineering.
He’s nothing more than a used car salesman.
Take TRXC on a “test drive” all ya want . You’ll get a lemon guaranteed.
Another Pope “Mistake” was to make the claim that they created Surgibot after interviews of 1000’s of surgeons to see what they wanted in a RASD. The result? Surgibot!
Not only was this SILS platform laughable, not one surgeon that I work with agreed that it was what “surgeons wanted”, (SILS flat out sucks) as a result (and my prediction) the FDA axed it faster than a dead tree welcoming a forest fire.
PRIOR to FDA denial of Surgiflop, Pope purchased “Telap ALF-X” from SOFAR who dumped it on him after 5 years of horrid clinical trials. He knew that Surgibot wasn’t up to snuff.
Alf-X was everything that Pope claimed surgeons DIDN’T WANT when he developed Surgibot. This was complete 180 from a design that was going to provide “Surveyed Surgeons”not only with “what they wanted” but a COMPLETELY different surgical approach.
In 2014, Pope told his doc’s that articulation in Alf instruments was coming by September 2015, a video still exists of a TRXC sponsored surgeon claiming (in May2015) that articulation was promised. It never happened. It never will. Patents by Intuitive surgical guarantees it. This is exactly why they are pumping 3mm instrumentation, it distracts investors from the limitations on lap sticks. He also pumps “advanced energy” LOL. This “advanced energy” has been around for decades but he obfuscates investors with “open architecture”. How many investors know what that means?
Open architecture simply means that any device can be used with the platform, nothing special here, but Pope hides this fact with the knowledge that 99% of investors have no idea about the OR and surgical instruments. Alf NEEDS open architecture so procedures can be preformed because Transenterix is not able (and can not afford) to produce dedicated instruments that work seamlessly with the device. EVERY procedure utilizes “open architecture” from Covidian, Ethicon, Baxter, Pfizer, Olympus, Medline, Asceulap, etc.... The list is endless. Yes Virginia, Davinci utilizes “open architecture” too. One single irrigation/suction device created by Stryker. Guess what? Intuitive now has a suction irrigation device that was created to work on a Davinci Xi arm that the surgeon can control from the console and Intuitive created it “in house”.
Price fluctuations on Transenterix are now in the Hands of MM’s and Hedge funds who are fleecing retail investors until eventual collapse.
I predicted the collapse at $5.00 while Surgibot was awaiting approval just 3 days before the FDA denial tanked the PPS to
.45 cents.
It’s coming once again.
Buyer beware
TransEnterix does not have a viable platform. Period. SOFAR was happy to dump ALF-X on TRXC because they knew after thousands of hours and hundreds of patients it was just not a viable platform. The clinical data sponsored by SOFAR and TRXC all display excessive surgical times, more post operative pain and a 6% conversion rate.
This platform has been available with a CE mark in Europe since 2013 and has yet to experience just one Commercial sale.
Well the fact is...Transenterix didn’t spend 10 “years on it”. They’ve had this platform for 5 years after purchasing it from a company that paid for the clinical studies and found it to be nonviable. Unfortunately, Pope bought it cheap, gave away 1/3 of his company in stock and is now scamming retail investors.
Tutes? Wanna follow them? May I remind you that those “Tutes” lost everything during the 2008 housing crash while one man said the “housing market was going to collapse”
They called him crazy too.
Nobody believed him either, in fact when he wanted to short the housing market there was no vehicle to do so. So they created one for him and he shorted housing market for over a year, losing money while those same “Tutes” tried keeping triple AAA credit ratings on the bonds that were garbage..
You’re welcome buddy. Keep us flying safe and we will do the same for our patients.
And yet after 10 years, they’ve never made a profit even with 2 prior FDA approved medical devices. SafeStitch & SPIDER.
Spider was shelved after no sales, a year after FDA approval and SafeStitch was responsible for anastomotic leaks on low anterior bowel resections that killed people. It was then pulled by the FDA.
Guess what Pope did right after the SafeStitch Fiasco, go ahead, guess.......
He changed the company name from “SafeStitch” to......
TRANSENTERIX!
The same way he changed the name of Telap-ALF X to... Senh....
A quote from your link....“It’s simple. Anything robotic is the future. And that included robotic surgical assistance”
Ummm, sorry, it’s not that “Simple”. First off it needs to provide advanced design over EXISTING TECHNOLOGY and ALF “Simply” doesn’t.
Todd Pope wants you to THINK “haptics and eye tracking” are improving existing technology. First and foremost, they’re not.
It’s deception at its finest. Like a magician, he will get you to look at one hand while his other hand is doing what he wants you not to see.
What Pope will NOT say is that Alf instrumentation is no different than Laparoscopic instruments designed 30 years ago, the huge footprint, ZERO commercial sales since the CE mark back in 2013 and no articulation except for a 10mm needle driver.
12mm scope? Really Todd? now you have 2 fascia closures while you convince investors that 3mm is the next best thing.
3mm instrumentation has been used in pediatrics for 10 years minimum and they do not reduce scarring any more than 5 & 8 mm incision when closed with 4-0 Monocryl and proper technique.
Buyer beware.
Quit sad actually. Pope is a genuine “Salesman”, I’ll give him that. Unfortunately he also knows (and doesn’t) what he’s doing... lining his pockets at investors expense.
I’m here to (hopefully) shine some light on that.
Have a great day!
Museum? We could call it the RASDAM.
Robotic Assisted Surgical Device Antiquated Museum.
I couldn’t stop laughing when I saw that. I knew it would make a fantastic avatar.
You’re quite welcome. It’s a shame to see investors get scammed but that’s exactly what is happening and Todd Pope knows it.
The vast majority of the general public has no idea of what happens inside of surgical services. The OR is off limits to 90% of the hospital. What happens inside is a mystery and it’s quite hard to understand the dynamics.
Even those that work inside of the OR are in the dark when it comes to Robotic Surgery and Robotic Assisted Surgical Device’s (RASD).
With that said, people seem to think that a 10 year old nonviable RASD is somehow “the latest and greatest” just because a salesman says it is.
My advice to anyone thinking of investing in TRXC has always been, Don’t do it, there are “too many moving parts” for you to understand in order to make a wise investment decision.
I called the Surgibot rejection 3 days before the FDA rejected it, I actually made some money for friends who bailed in the 5’s. I also called the FDA rejection of ALF, and guess what? I was right. I was always my contention that the huge 4 arm footprint was not only impractical, but dangerous. The FDA agreed and that is exactly why Alf is only available in the United States with 3 arms. The FDA either denied or told pope in advance that 4 arms would not be approved. So he is forging ahead with a 3 arm behemoth without warning investors.
That was a death blow as there is absolutely no way Alf is able to provide the basic dissection technique of counter traction on its own.
The surgeon is now at the mercy of an assistant, and patients are going to pay for it.
Shame on you Pope.
Times I posted are based on Clinical data, they’re average times based on SOFARS most experienced surgeons. These surgeons were not “just starting out”, they had hundreds of cases under their belts. I could have posted the ALF TAHBSO High time of 210 minutes but chose not to.
Even though you’re assumption as to “why I’m here” is irrelevant, it’s also wrong and none of your business.
However...
I’m here to discuss a nonviable Surgical Robotic platform to help investors make a wise decision based on clinical data and my 5K + hours in Robotic Surgery along with 18 years experience in the OR.
Well I doubt Rick wise is a surgeon but I can provide you with a comment that one of our RASD surgeons had after he demoed ALF at SAGES. I asked he what he thought. His reply?
“It’s a piece of junk”.
He must be the only Surg Tech in the world that hospitals allow to perform surgery LOL
The title is CSTFA and they’re 10’s of thousands of them. Know much about surgery do ya?
Pope made a MAJOR change to their multi port, 2009, Italian made platform that was dumped on them by SOFAR. What did he do?
He changed the Name so that noobie, uneducated investors who might (by some miracle) stumble upon the horrid clinical data wouldn’t know Alf is actually Popes “New FDA approved RASD”. It’ll never be called (by me) what Pope named it (Sen*****) because I refuse to recognize his obfuscation of a name just to fleece investors.
Alf instruments are no different than Laparoscopic instruments which were designed 30 years ago. Alf times are 4 to 7 times longer than a Davinci Xi and still 4 times longer than the Si which Davinci started phasing out 2 years ago. Alf is 10 years old without one single COMMERCIAL sale. Alf takes an average of 147 minutes to do a TAHBSO while the Xi averages 25 minutes.
Think.
“And taking the word of a Surg Techs advice on a surgical robot would be like asking a airplane mechanic how the plane fly's
Ummm.. try that in reverse. More like asking the Pilot how to troubleshoot the Mechanics of the plane.
Surgeons know anatomy, it’s the RASD tech’s job to know the platform and make sure it’s working correctly BEFORE the surgeon enters the room. RASD techs (yes, they’re specialized) troubleshoot instruments, and the platform when the surgeons have a problem.
You’ve obviously never been in the OR.